Skip to content
About CombiGene
Projects
The pain program COZY
The epilepsy project CG01
The lipodystrophy project CGT2
Patent
The Market
Organization
Investors
Financial reports
Prospectus/IM
Financial calendar
Company and share information
Nasdaq First North Growth Market
Corporate governance
Organization
Articles of association
Company description
IR-contact
Certified Adviser
Media
Press releases
Presentations
Ingeneious
Calendar
Contact
Contact us
Downloads
About CombiGene
Projects
The pain program COZY
The epilepsy project CG01
The lipodystrophy project CGT2
Patent
The Market
Organization
Investors
Financial reports
Prospectus/IM
Financial calendar
Company and share information
Nasdaq First North Growth Market
Corporate governance
Organization
Articles of association
Company description
IR-contact
Certified Adviser
Media
Press releases
Presentations
Ingeneious
Calendar
Contact
Contact us
Downloads
SV
Calendar
No events currently planned
We will update later welcome back.
News
November 27, 2023
New issue of Ingeneious, no 5 2023
November 10, 2023
Interim report January – September 2023 for CombiGene AB (publ)
October 31, 2023
CombiGene chooses Charles River as preclinical toxicology partner for COZY01 pain project
October 26, 2023
CombiGene and Zyneyro choose initial indication in the COZY01 pain project
October 25, 2023
CombiGene AB (publ): Nominating committee
October 14, 2023
Spark Therapeutics terminates collaboration agreement for the epilepsy project CG01 with CombiGene
Load more
